copa3 peptide from copris tripartitus induces apoptosis in human leukemia cells via a caspase-independent pathway

Clicks: 247
ID: 195003
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #13 of 15 articles by views in canadian journal of physiology and pharmacology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Our previous study demonstrated that CopA3, a disulfide dimerof the coprisin peptide analogue (LLCIALRKK), has antibacterialactivity. In this study, we assessed whether CopA3caused cellular toxicity in various mammalian cell lines.CopA3 selectively caused a marked decrease in cell viabilityin Jurkat T, U937, and AML-2 cells (human leukemia cells),but was not cytotoxic to Caki or Hela cells. Fragmentation ofDNA, a marker of apoptosis, was also confirmed in the leukemiacell lines, but not in the other cells. CopA3-induced apoptosisin leukemia cells was mediated by apoptosis inducingfactor (AIF), indicating induction of a caspase-independent signalingpathway. [BMB reports 2012; 45(2): 85-90]
Reference Key
kang2012bmbcopa3 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal canadian journal of physiology and pharmacology
Year 2012
DOI
http://dx.doi.org/10.5483/BMBRep.2012.45.2.85
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.